We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CytoDyn Doses First Patient in Phase 2b/3 Trial of Leronlimab for COVID-19
CytoDyn Doses First Patient in Phase 2b/3 Trial of Leronlimab for COVID-19